BB
BB Biotech AG
BBAGF · OTC
$64.36 +5.20% (+$3.18)
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Debt/Assets N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
51 /100
Moderate Beta 0.60x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BBAGF
Online
Sector
Financial Services
Industry
Asset Management
CEO
Daniel Koller
Employees
10
Headquarters
Kusnacht
Upcoming events
23 OCT
Earnings
Upcoming earnings report